==== Front Int J Surg Case RepInt J Surg Case RepInternational Journal of Surgery Case Reports2210-2612Elsevier S2210-2612(18)30277-310.1016/j.ijscr.2018.07.027ArticleMultiple mesenteric desmoid tumors after gastrectomy for gastric cancer: A case report and literature review Yamamoto Ryusei public.lock.on@gmail.com⁎Mokuno Yasuji y-mokuno@ra2.so-net.ne.jpMatsubara Hideo doctorhideoow@yahoo.co.jpKaneko Hirokazu h-kane@med.nagoya-u.ac.jpIyomasa Shinsuke siyomasa@yachiyo-hosp.or.jpDepartment of Surgery, Yachiyo Hospital, 2-2-7, Sumiyoshi-cho, Anjo-shi, Aichi, 446-8510, Japan⁎ Corresponding author. public.lock.on@gmail.com31 7 2018 2018 31 7 2018 50 50 55 13 6 2018 24 7 2018 © 2018 The Author(s)2018This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Highlights • A desmoid tumor often occurs at a surgical site of familial adenomatous polyposis. • Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer. • It is difficult to differentiate mesenteric desmoids from a cancer recurrence. • Surgical resection of the tumors is a useful option as a diagnostic therapy. Introduction Many patients with desmoids have an antecedent trauma, particularly surgical intervention for familial adenomatous polyposis. However, cases of mesenteric desmoid after gastrectomy are extremely rare. We present a case of multiple mesenteric desmoids after total gastrectomy for gastric cancer. Presentation of case A 70-year-old man had undergone a total gastrectomy for early stage gastric cancer. He had no other relevant medical history or family history. A year after gastrectomy, a computed tomography showed three mesenteric masses, and we performed careful observation. The 2-year postoperative examination indicated slowly growing masses. There were no other lesions except for the three masses. We decided to perform diagnostic surgery to evaluate the tumors. There were three mesenteric masses (1.5 cm, 4 cm and 1.5 cm in diameter). We performed partial small intestinal resections for each mass. Histological examination showed that the tumors were desmoids. A year after surgery, he was doing well with no evidence of recurrence of the desmoids or the gastric cancer. Discussion Diagnosing intra-abdominal desmoid tumors is often difficult. Especially if a patient has a history of malignancy, it may be extremely difficult to differentiate multiple mesenteric desmoids from a cancer recurrence. In the current case, surgical resection was a useful treatment option as diagnostic therapy. Conclusions Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer, and surgical resection of the tumors is a useful option as a diagnostic therapy. Abbreviations FAP, familial adenomatous polyposisCT, computed tomographyCEA, carcinoembryonic antigenCA 19-9, carbohydrate antigen 19-9PET, positron emission tomographyFDG, fluorodeoxyglucoseSUVmax, maximum standard uptake valueKeywords Case reportIntra-abdominalMultipleDesmoidGastrectomyGastric cancer ==== Body 1 Introduction Desmoids are rare tumors, and the estimated incidence is reported to be 2–4 per million population per year [1]. Although desmoids lack the potential for distant metastases, desmoid tumors are locally aggressive and can destroy vital organs, especially intra-abdominal desmoids that often result in fatal outcomes [2]. Most desmoid tumors are asymptomatic unless the destruction of organs has occurred. It is known that about 30 percent of patients with desmoids have an antecedent trauma, particularly a surgical intervention for familial adenomatous polyposis (FAP) [[3], [4], [5]]. However, cases of mesenteric desmoid after gastrectomy for gastric cancer are extremely rare, and there have been few reports in the literature [[6], [7], [8], [9]]. We present a case of multiple mesenteric desmoids after total gastrectomy for gastric cancer with a review of the relevant literature in line with the SCARE criteria [10]. 2 Presentation of case A 70-year-old Asian man had undergone total gastrectomy for a gastric cancer, and a Roux-en-Y esophagojejunostomy was performed. Histological examination of the tumor showed moderately differentiated tubular adenocarcinoma, and the tumor was classified as pT1N0M0, stage IA according to the Union for International Cancer Control classification, 7th edition. He had an uneventful postoperative course. He had no other medical history or family history. One year post-gastrectomy, he was asymptomatic, but the CT showed three mesenteric masses (0.5 cm, 2.5 cm and 1 cm in diameter). Based on mutual agreement with the patient that he required monitoring, we performed careful observation without surgical resection or chemotherapy. Then, the 2-year postoperative CT indicated slowly growing masses (1.5 cm, 4 cm and 1.5 cm in diameter, as shown in Fig. 1). The tumor marker levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) had been within normal limits. Positron emission tomography (PET) revealed fluorodeoxyglucose (FDG) uptake of two masses, and the maximum standard uptake value (SUVmax) of the largest mass was 4.1 (Fig. 2). There were no swollen lymph nodes, and there was neither ascites nor other distant metastases. We firstly suspected relapse of the gastric cancer; however, the recurrence was uncertain, and the possibility of another tumor was suspected because the gastric cancer had been diagnosed at a very early stage, the growth speed of the masses was leisurely and the number of masses was not increased. Therefore, we decided to perform a diagnostic operation to determine the tumor type.Fig. 1 CT showing 3 enhanced, round-shaped masses mimicking gastric cancer lymph nodes or peritoneal dissemination recurrence that increased in size but not in number. Small characters indicate the CT a year after gastrectomy, and large characters indicate the CT two years after gastrectomy. a: 0.5 cm, b: 2.5 cm, c: 1.0 cm in diameter. A: 1.5 cm, B: 4 cm, C: 1.5 cm in diameter. Fig. 1Fig. 2 Positron emission tomography revealing FDG uptake of two masses, although one mass did not take up FDG. a: A small mass with mild uptake of FDG, b: a large mass with uptake of FDG; the maximum standard uptake value of 4.1, c: a small mass without uptake of FDG. Fig. 2 We continuously performed a laparotomy to resect and survey the masses. There were three mesenteric masses near the bowel: a 1.5-cm diameter mass, 20 cm distal from the jejunojejunostomy; a 4-cm diameter mass, 80 cm distant from the jejunojejunostomy, and a 1.5-cm diameter mass, 120 cm distant from the jejunojejunostomy (Fig. 3). We performed partial small intestinal resections for each mass. Histological examination showed desmoid tumors that were 15 × 12 mm, 40 × 40 mm and 15 × 13 mm (Fig. 4). Immunology testing indicated β-catenin (+). The patient had an uneventful postoperative course. A year after surgery, he was doing well with no evidence of recurrence of the desmoid tumors or the gastric cancer.Fig. 3 Intraoperative pictures showing 3 masses of the jejunal mesentery close to the jejunum. a: 3-cm mass mimicking peritoneal dissemination, 20 cm from the jejunojejunostomy, b: a 4-cm round mass with a pellicle, 80 cm from the jejunojejunostomy, and a 1.5-cm mass mimicking peritoneal dissemination, 120 cm from the jejunojejunostomy. Fig. 3Fig. 4 a: Gross appearance of the largest mesenteric desmoid tumor that was resected with negative surgical margins. b: Histological examination revealing spindle-shaped cells and collagen fibers (hematoxylin and eosin stain). c: Immunostaining showing diffuse β-catenin positive. Fig. 4 3 Discussion Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer. Typically, a desmoid tumor is solitary and occurs at the extremities or abdominal wall in premenopausal woman or at the surgical site in patients with FAP [[11], [12], [13]]. It was reported that about 50 percent of all desmoid tumors are intra-abdominal, but cases in patients without FAP accounted for only about 10 percent [1,14]. Although rare, there are some reports of multiple mesenteric desmoids that were difficult to distinguish from the recurrence of malignancy [9,15,16]. We found six cases of intra-abdominal desmoid tumor after gastrectomy for gastric cancer (Table 1) [[6], [7], [8], [9]]. Moreover, two of six cases including our case manifested multiple mesenteric tumors. The diagnostic difficulty would remain unrecognized due to the wrong diagnosis of gastric cancer recurrence, and as matter of fact, in two of six reported cases, chemotherapy had been performed prior to the surgical resection. Therefore, we presumed that there could be more hidden desmoid cases. We should be aware that desmoid could manifest as multiple mesenteric tumors after gastrectomy for gastric cancer.Table 1 Desmoid tumors after gastrectomy for gastric cancer. Table 1Author Age Sex Antecedent gastrectomy Pathology (adeno- carcinoma) Stage Duration (months) Size (mm) SUVmax of PET Tumor markers Sites of mesentery Initial diagnosis Treatment Recurrence Komatsu et al. 50 M Total Well T3N0M0, stage IIA 12 50 * * Jejunum* Recurrence Chemotherapy > Operation No Tamura et al. 73 F Total * T1N0M0, stage IA 24 63 * Normal Jejunal pouch * Operation No Okamura et al. 57 M Distal Poorly T2N0M0, stage IB 27 40 3.9 Elevated Transverse colon Recurrence Chemotherapy > Operation No Kim et al. 50 M Distal Poorly T1N1M0, stage IB 24 50, 60 * * Jejunum nearby and 100-cm distal from gastrojejunostomy Recurrence or Benign tumor Operation No Kim et al. 60 M Total Mucinous T2N2M0, stage IIB 23 60 Mild * Ileum 30-cm proximal from ileocecal valve Recurrence Operation No Our case 70 M Total Moderately T1N0M0, stage IA 12 15, 40, 15 4.1 Normal Jejunum 20-cm distal and 80-cm distal and 120-cm distal from jejunojejunostomy Recurrence or Benign tumor Operation No PET: positron emission tomography; SUVmax: maximum standard uptake value. *Details were not described. Surgical resection of the tumors could be a useful diagnostic and treatment option in this setting. Diagnosing intra-abdominal desmoids is often difficult. In this case, the desmoids did not have a specific feature on CT, which showed an enhanced round-shaped mass mimicking gastric cancer lymph nodes or peritoneal dissemination recurrence [[6], [7], [8], [9]]. The desmoids had mild uptake of FDG on PET, and the SUVmax did not allow us to make a differential diagnosis between a desmoid and a recurrence of the gastric cancer [8,9]. Tumor marker levels might help us to distinguish a desmoid tumor from the recurrence of gastric cancer. Although CEA is often elevated in a case of gastric cancer recurrence, it is not relevant for desmoid tumors; nevertheless, a case of desmoid tumor with cryptogenic elevation of serum CEA levels was reported [8]. Thus, the diagnosis of desmoid tumors can be established only by histological examination of the biopsy specimen. However, core needle biopsy of an intra-abdominal tumor has a risk of dissemination. Moreover, if a patient has a prior history of malignancy, it may be extremely difficult to differentiate between multiple mesenteric desmoids and disease recurrence. Because desmoid tumors lack metastatic potential, treatment strategies for these tumors are careful observation or local therapies [[17], [18], [19], [20]]. On the other hand, most cancer recurrences would be treated with systemic therapy, but a metastasectomy is hardly indicated, especially in cases with multiple metastatic masses. In terms of the treatment strategy, there is a big difference between these two diagnoses. Therefore, differential diagnosis is very important, but it remains difficult to distinguish multiple mesenteric desmoid tumors from a cancer recurrence preoperatively. We elucidated that the surgical resection is, if technically possible, a useful option as diagnostic therapy. Further reports should be accumulated about the preoperative differentiation between multiple mesenteric desmoid tumors and disease recurrence. Although the differential diagnosis of multiple mesenteric desmoid tumors was difficult, it was evident that the treatment plan should be decided based on the diagnostic imaging. In general, initial careful observation seemed to be an acceptable treatment option for asymptomatic desmoids, whereas surgical resection with negative surgical margins was the feasible treatment when it was technically practicable [[17], [18], [19], [20]]. In cases with an antecedent malignancy, however, a recurrence of that cancer should be excluded, especially for the observation strategy. In our case, we considered the possibility of primary mesenteric tumors for the following reasons: the original gastric cancer was early stage; the three masses were on the mesentery, distant from the previous surgical site without regional lymph node swelling; the masses increased in size but not in number; ascites was never seen; and the tumor marker levels had been within normal limits. Additionally, we considered those three tumors resectable on the diagnostic imaging. Taken together, these factors led us to perform surgical resection as diagnostic therapy. 4 Conclusions Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer. If a patient has an antecedent history of malignancy, it may be extremely difficult to differentiate between multiple mesenteric desmoids and disease recurrence. In terms of the treatment strategy, there is a big difference between the two diagnoses. We stressed that the surgical resection was, if technically practicable, a useful treatment option as diagnostic therapy. Conflicts of interest All authors declare that they have no conflicts of interest. Funding All authors declare that they have no funding. Ethical approval The institutional ethics committee approved the publication of this case report. Consent Written informed consent was obtained from the patient for publication of this case report and any accompanying images. Author contribution All authors contributed to the concept of this case report. Ryusei Yamamoto drafted the manuscript. Yasuji Mokuno revised the manuscript. Hideo Matsubara, Hirokazu Kaneko and Sinsuke Iyomasa supervised the writing of the report. All authors participated in interpreting the results and writing the report; all authors approved the final version of the manuscript. Registration of research studies This case report is not mandatory for human study. Guarantor Iyomasa Shinsuke. Acknowledgment None. ==== Refs References 1 Reitamo J.J. Hayry P. Nykyri E. Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population Am. J. Clin. Pathol. 77 1982 665 673 7091046 2 Arvanitis M.L. Jagelman D.G. Fazio V.W. Lavery I.C. McGannon E. Mortality in patients with familial adenomatous polyposis Dis. Colon Rectum 33 1990 639 642 2165452 3 Lopez R. Kemalyan N. Moseley H.S. Dennis D. Vetto R.M. Problems in diagnosis and management of desmoid tumors Am. J. Surg. 159 1990 450 453 2139764 4 Schlemmer M. Desmoid tumors and deep fibromatoses Hematol. Oncol. Clin. North Am. 19 2005 565 571 vii-viii 15939197 5 Schiessling S. Kihm M. Ganschow P. Kadmon G. Buchler M.W. Kadmon M. Desmoid tumour biology in patients with familial adenomatous polyposis coli Br. J. Surg. 100 2013 694 703 23334997 6 Komatsu S. Ichikawa D. Kurioka H. Koide K. Ueshima Y. Shioaki Y. Intra-abdominal desmoid tumor mimicking lymph node recurrence after gastrectomy for gastric cancer J. Gastroenterol. Hepatol. 21 2006 1224 1226 16824087 7 Tamura K. Tani M. Kinoshita H. Yamaue H. Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy World J. Surg. Oncol. 4 2006 27 16740152 8 Okamura A. Takahashi T. Saikawa Y. Mayanagi S. Fukuda K. Nakamura R. Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report World J. Surg. Oncol. 12 2014 146 24884980 9 Kim P.S. Han D.S. Han H.S. Bang H.Y. Intra-abdominal fibromatosis after gastrectomy for gastric cancer Ann. Surg. Treat. Res. 87 2014 331 335 25485242 10 Agha R.A. Fowler A.J. Saetta A. Barai I. Rajmohan S. Orgill D.P. for the SCARE Group The SCARE statement: consensus-based surgical case report guidelines Int. J. Surg. 34 2016 180 186 27613565 11 Fong Y. Rosen P.P. Brennan M.F. Multifocal desmoids Surgery 114 1993 902 906 8236012 12 Quintini C. Ward G. Shatnawei A. Xhaja X. Hashimoto K. Steiger E. Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: a single center review of 154 patients Ann. Surg. 255 2012 511 516 22323009 13 Fiore M. Coppola S. Cannell A.J. Colombo C. Bertagnolli M.M. George S. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk Ann. Surg. 259 2014 973 978 24477160 14 Fallen T. Wilson M. Morlan B. Lindor N.M. Desmoid tumors — a characterization of patients seen at Mayo Clinic 1976-1999 Fam. Cancer 5 2006 191 194 16736290 15 Nakanishi K. Shida D. Tsukamoto S. Ochiai H. Mazaki J. Taniguchi H. Multiple rapidly growing desmoid tumors that were difficult to distinguish from recurrence of rectal cancer World J. Surg. Oncol. 15 2017 180 28974244 16 Das S. Subhashini J. Isiah R. Kurian S. Mesenteric fibromatosis mimicking metastasis: a case report and review of literature J. Gastrointest. Cancer 43 Suppl. 1 2012 S73 S76 21710175 17 Ballo M.T. Zagars G.K. Pollack A. Pisters P.W. Pollack R.A. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy J. Clin. Oncol. 17 1999 158 167 10458229 18 Kulaylat M.N. Karakousis C.P. Keaney C.M. McCorvey D. Bem J. Ambrus J.L. Sr Desmoid tumour: a pleomorphic lesion Eur. J. Surg. Oncol. 25 1999 487 497 10527597 19 Fiore M. Rimareix F. Mariani L. Domont J. Collini P. Le Pechoux C. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment Ann. Surg. Oncol. 16 2009 2587 2593 19568815 20 Bonvalot S. Ternes N. Fiore M. Bitsakou G. Colombo C. Honore C. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought Ann. Surg. Oncol. 20 2013 4096 4102 24052312